Elution of unmodified oligodeoxynucleotides from zinc-Imidazole negatively stained polyacrylamide gels
被引:0
|
作者:
Ctr. for Genetic Eng. and Biotech., P. O. Box 6162, Havana, 10600, Cuba
论文数: 0引用数: 0
h-index: 0
Ctr. for Genetic Eng. and Biotech., P. O. Box 6162, Havana, 10600, Cuba
[1
]
机构:
来源:
Anal. Biochem.
|
/
1卷
/
127-129期
关键词:
Acknowledgments. A.J.H. is a Wellcome Trust Senior Biomedical Research Fellow and this project was supported by a Wellcome trust grant to W.J.R. L.F. and T.D. are supported by the Cancer Research Campaign;
机构:
NCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USANCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USA
WU, RS
STEDMAN, JD
论文数: 0引用数: 0
h-index: 0
机构:
NCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USANCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USA
STEDMAN, JD
WEST, MHP
论文数: 0引用数: 0
h-index: 0
机构:
NCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USANCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USA
WEST, MHP
PANTAZIS, P
论文数: 0引用数: 0
h-index: 0
机构:
NCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USANCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USA
PANTAZIS, P
BONNER, WM
论文数: 0引用数: 0
h-index: 0
机构:
NCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USANCI, DIV CANC TREATMENT, PROGRAM DEV THERAPEUT, MOLEC PHARMACOL LAB, BETHESDA, MD 20205 USA